Whilst not currently included as a MetS trait characterising MASLD [1, 6], we were not able to explore the impact of insulin resistance on the risk of CKD since fasted glucose and insulin concentrations are not available within the UK BioBank cohort. Here, INS is linked to metabolic syndrome.